4.7 Article

Antigen-specific effector CD8 T cells regulate allergic responses via IFN-γ and dendritic cell function

Journal

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
Volume 129, Issue 6, Pages 1611-+

Publisher

MOSBY-ELSEVIER
DOI: 10.1016/j.jaci.2011.12.976

Keywords

Asthma; OT-I; IFN-gamma(-/-) OT-I; CD8 T cells; effector; IFN-gamma; eosinophils; CD11b(+)CD103(-)DC; T(H)1

Funding

  1. Biomedical Research Council [BMRC 05/1/21/19/41]
  2. National University of Singapore
  3. National Research Foundation HUJ-CREATE

Ask authors/readers for more resources

Background: Previous studies have shown that CD8 T cells can both prevent and cause allergic responses. However, the underlying mechanisms remain to be elucidated. Objective: We aim to investigate the potential of CD8 T cells with different IFN-gamma expressions to modulate the elicitation of allergic inflammation following ovalbumin (OVA) challenge and investigate the underlying mechanisms. Methods: To study the role of IFN-gamma in the effect of CD8 T cells, effector CD8 T cells from CD8 OVA transgenic (OT-I) mice and IFN-gamma(-/-) OT-I mice were transferred to OVA-sensitized mice the day before 3 challenges with OVA. The effect on lung dendritic cells (DCs) exerted by CD8 T cells was studied with ex vivo culture of sorted DCs from treatment mice with CD4 T cells. Results: Effector OT-I, but not IFN-gamma(-/-) OT-I CD8 T cells, attenuated eosinophilia and mucus secretion in the lungs of sensitized mice in an antigen-specific manner. Effector IFN-gamma(-/-) OT-I CD8 T cells displayed a Tc2-/Tc17-biased phenotype with weaker cytotoxicity and were able to both induce and exacerbate eosinophilia as well as neutrophilia. OT-I CD8 T cells increased the ability of lung CD11b(+)CD103(-) DCs to both prime the differentiation of naive OVA-specific CD4 T cells toward a T(H)1 phenotype and enhance IFN-gamma production by antigen-experienced lung CD4 T cells. Conclusion: Effector CD8 T cells attenuate pulmonary inflammation and alter the ability of DCs within the allergic lung to polarize T cells to a T(H)1 phenotype during a T(H)2 response. In the absence of IFN-gamma, CD8 T cells assume a Tc2-/Tc17-biased phenotype and potentiate inflammation. (J Allergy Clin Immunol 2012; 129: 1611-20.)

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Immunology

The Syk-NFAT-IL-2 Pathway in Dendritic Cells Is Required for Optimal Sterile Immunity Elicited by Alum Adjuvants

Hanif Javanmard Khameneh, Adrian W. S. Ho, Roberto Spreafico, Heidi Derks, Hazel Q. Y. Quek, Alessandra Mortellaro

JOURNAL OF IMMUNOLOGY (2017)

Article Pharmacology & Pharmacy

Targeting the renin-angiotensin system as novel therapeutic strategy for pulmonary diseases

Wan Shun Daniel Tan, Wupeng Liao, Shuo Zhou, Dan Mei, Wai-Shiu Fred Wong

CURRENT OPINION IN PHARMACOLOGY (2018)

Editorial Material Respiratory System

International research collaboration: The way forward

Sanjay H. Chotirmall, Sven-Erik Dahlen, Christopher Carlsten, W. S. Fred Wong, Kian F. Chung, Reinoud Gosens, Darryl A. Knight

RESPIROLOGY (2018)

Article Medicine, Research & Experimental

Ribosomal Protein S3 Gene Silencing Protects Against Cigarette Smoke-Induced Acute Lung Injury

Jinrui Dong, Wupeng Liao, Hong Yong Peh, W. S. Daniel Tan, Shuo Zhou, W. S. Fred Wong

MOLECULAR THERAPY-NUCLEIC ACIDS (2018)

Article Immunology

Scavenging Circulating Mitochondrial DNA as a Potential Therapeutic Option for Multiple Organ Dysfunction in Trauma Hemorrhage

Andrew Aswani, Joanna Manson, Kiyoshi Itagaki, Fausto Chiazza, Massimo Collino, Winston Liao Wupeng, Tze Khee Chan, W. S. Fred Wong, Carl J. Hauser, Chris Thiemermann, Karim Brohi

FRONTIERS IN IMMUNOLOGY (2018)

Article Pharmacology & Pharmacy

Gene silencing of receptor-interacting protein 2 protects against cigarette smoke-induced acute lung injury

Jinrui Dong, Wupeng Liao, Lay Hong Tan, Amy Yong, Wen Yan Peh, W. S. Fred Wong

PHARMACOLOGICAL RESEARCH (2019)

Article Pharmacology & Pharmacy

Andrographolide simultaneously augments Nrf2 antioxidant defense and facilitates autophagic flux blockade in cigarette smoke-exposed human bronchial epithelial cells

W. S. Daniel Tan, Wupeng Liao, Hong Yong Peh, Merima Vila, Jinrui Dong, Han-Ming Shen, W. S. Fred Wong

TOXICOLOGY AND APPLIED PHARMACOLOGY (2018)

Article Pharmacology & Pharmacy

Pharmacological strategies to regain steroid sensitivity in severe asthma and COPD

Dan Mei, Wan Shun Daniel Tan, Wai Shiu Fred Wong

CURRENT OPINION IN PHARMACOLOGY (2019)

Article Chemistry, Medicinal

The identification of naturally occurring labdane diterpenoid calcaratarin D as a potential anti-inflammatory agent

Quy T. N. Tran, W. S. Fred Wong, Christina L. L. Chai

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)

Review Pharmacology & Pharmacy

Dysregulated autophagy in COPD: A pathogenic process to be deciphered

W. S. Daniel Tan, Han-Ming Shen, W. S. Fred Wong

PHARMACOLOGICAL RESEARCH (2019)

Article Pharmacology & Pharmacy

Restoration of HDAC2 and Nrf2 by andrographolide overcomes corticosteroid resistance in chronic obstructive pulmonary disease

Wupeng Liao, Albert Y. H. Lim, W. S. Daniel Tan, John Abisheganaden, W. S. Fred Wong

BRITISH JOURNAL OF PHARMACOLOGY (2020)

Article Medicine, Research & Experimental

Comprehensive engineering of a therapeutic neutralizing antibody targeting SARS-CoV-2 spike protein to neutralize escape variants

Taichi Kuramochi, Siok Wan Gan, Adrian W. S. Ho, Bei Wang, Nagisa Kageji, Takeru Nambu, Sayaka Iida, Momoko Okuda-Miura, Wei Shan Chia, Chiew Ying Yeo, Dan Chen, Wen-Hsin Lee, Eve Zi Xian Ngoh, Siti Nazihah Mohd Salleh, Cheng- Wang, Tomoyuki Igawa, Hideaki Shimada

Summary: This study demonstrates that through comprehensive engineering of the variable region, the engineered antibody, 5A6CCS1, is able to neutralize SARS-CoV-2 variants that escaped neutralization by the original antibody. In addition to improved affinity against variants, 5A6CCS1 was optimized for high solubility and low viscosity, enabling a high concentration formulation for subcutaneous injection. In animal experiments, 5A6CCS1 showed promising characteristics, highlighting the potential of antibody engineering to counteract escape variants.
Article Pharmacology & Pharmacy

Calcaratarin D, a labdane diterpenoid, attenuates mouse asthma via modulating alveolar macrophage function

Wupeng Liao, Hazel Yu Ci Foo, Thi Ngoc Quy Tran, Christina Li Lin Chai, Wai Shiu Fred Wong

Summary: This study evaluated the protective effects of CalD in a house dust mite (HDM)-induced asthma mouse model. CalD reduced various inflammatory markers and improved lung function in the mice. It modulated the function of alveolar macrophages and had potential as a novel anti-inflammatory compound for allergic asthma.

BRITISH JOURNAL OF PHARMACOLOGY (2023)

Article Engineering, Biomedical

Multifunctional Antibacterial Nanonets Attenuate Inflammatory Responses through Selective Trapping of Endotoxins and Pro-Inflammatory Cytokines

Nhan Dai Thien Tram, Quy Thi Ngoc Tran, Jian Xu, Jeannie Ching Ting Su, Wupeng Liao, Wai Shiu Fred Wong, Pui Lai Rachel Ee

Summary: Due to the failure of target-specific strategies, a novel multifunctional biomaterial based on peptide nanonets has been developed to selectively trap lipopolysaccharide (LPS), tumor necrosis factor-alpha (TNF-alpha), and interleukin-6 (IL-6) in order to suppress inflammation and restore the antimicrobial activity of the last-resort antibiotic colistin. In addition to its ability to simultaneously trap and kill bacteria, the peptide nanonets have shown remarkable potential as a holistic anti-infective and anti-septic biomaterial.

ADVANCED HEALTHCARE MATERIALS (2023)

Review Biochemistry & Molecular Biology

Polypharmacology of andrographolide: beyond one molecule one target

Quy T. N. Tran, W. S. Daniel Tan, W. S. Fred Wong, Christina L. L. Chai

Summary: Andrographolide, a widely studied plant secondary metabolite, has diverse pharmacological targets associated with prevalent diseases. Despite documented efficacy in disease models, challenges such as multi-targeting properties and discrepancies in bioavailability have hindered its development as a therapeutic agent.

NATURAL PRODUCT REPORTS (2021)

No Data Available